Desmopressin with four-factor prothrombin complex concentrate for life-threatening bleeding: A case series

Am J Emerg Med. 2020 Dec;38(12):2634-2636. doi: 10.1016/j.ajem.2020.07.082. Epub 2020 Aug 8.
No abstract available

MeSH terms

  • Aged
  • Aged, 80 and over
  • Anticoagulants / adverse effects*
  • Aspirin / adverse effects
  • Blood Coagulation Factors / therapeutic use*
  • Cerebral Hemorrhage, Traumatic / etiology
  • Cerebral Hemorrhage, Traumatic / therapy
  • Cerebral Intraventricular Hemorrhage / chemically induced
  • Cerebral Intraventricular Hemorrhage / therapy*
  • Clopidogrel / adverse effects
  • Deamino Arginine Vasopressin / therapeutic use*
  • Female
  • Fractures, Bone / complications
  • Hematoma / etiology
  • Hematoma / therapy
  • Hematoma, Subdural, Intracranial / etiology
  • Hematoma, Subdural, Intracranial / therapy
  • Hemostatics / therapeutic use*
  • Humans
  • International Normalized Ratio
  • Intracranial Hemorrhage, Traumatic / drug therapy*
  • Intracranial Hemorrhage, Traumatic / etiology
  • Male
  • Middle Aged
  • Pelvic Bones / injuries
  • Platelet Aggregation Inhibitors / adverse effects*
  • Pyrazoles / adverse effects
  • Pyridones / adverse effects
  • Retrospective Studies
  • Rivaroxaban / adverse effects
  • Subarachnoid Hemorrhage, Traumatic / etiology
  • Subarachnoid Hemorrhage, Traumatic / therapy
  • Thrombosis / chemically induced
  • Thrombosis / epidemiology
  • Warfarin / adverse effects

Substances

  • Anticoagulants
  • Blood Coagulation Factors
  • Hemostatics
  • Platelet Aggregation Inhibitors
  • Pyrazoles
  • Pyridones
  • prothrombin complex concentrates
  • apixaban
  • Warfarin
  • Rivaroxaban
  • Clopidogrel
  • Deamino Arginine Vasopressin
  • Aspirin